Program

Director Scientific and Regulatory Affairs at Food Supplements Europe, Belgium
This presentation will provide an up-to-date status on the various regulatory aspects relating to food supplements, with a peek into possible future developments. It will address future harmonsaition of maximum levels of vitamins and minerals and present Food Supplements Europe’s activities to promote the role of food supplements for public health and to strengthen innovation and competitiveness of the sector.

Head Supplements, Biologically Active and Psychoactive Substances, Croatian National Institute of Public Health
Food supplements play a significant role in the growing trend of self-medication and preventive health. Due to their effectiveness and pharmaceutical-like forms, consumers often perceive them as medicines. Global trends continue to introduce innovations, new ingredients, and diverse types of supplements.
When launching a product on the market, ensuring its safety is essential. However, the quality and quantity of biologically active ingredients, along with appropriate labeling, are also critical to overall health safety. Health claims serve to link active ingredients and their dosages with specific health benefits, helping consumers make informed choices based on their individual needs.
As the general population increasingly uses food supplements—and as their variety expands—the frequency of side effects is also rising. Interactions between active substances from multiple supplements, as well as with food or medications, further contribute to potential risks.
Nutrivigilance refers to the system of activities involved in identifying, evaluating, and monitoring adverse effects related to the consumption of food and food supplements. To assess and categorize these risks to individual health, some EU countries have proactively implemented national nutrivigilance systems. Croatia established its own Nutrivigilance National System five years ago, introducing a public reporting tool with a structured questionnaire designed to gather information on side effects, raise awareness, and support broader public health efforts.

General Secretary, The Romanian Food Supplements Industry Association, Prisa, Romania
The presentation provides an overview of the food supplements sector in Romania, highlighting both market dynamics and the regulatory environment. As an emerging market within the European Union, Romania illustrates key trends in consumer demand, the increasing need for proportionate regulation, and the growing importance of transparent, science-based communication with consumers.
The Romanian Food Supplements Industry Association outlines its role in supporting product safety, responsible marketing, and industry self-regulation, while also addressing national challenges—such as restrictive advertising rules and uneven implementation of EU law.
The presentation advocates for better regulatory harmonization, enhanced collaboration between stakeholders, and a shared commitment to consumer education. It concludes with key recommendations and an open invitation for cross-border cooperation in promoting responsible use of food supplements.

Technical Director, Council for Responsible Nutrition UK (CRN-UK)

Director of Public Affairs, Herbalife, Türkiye

General Secretary, Europam - the European Herb Growers Association, Italy
Europam is strongly committed to ensuring the quality of medicinal herbs cultivated in Europe. The high
standards demanded by the market—especially when these herbs are used as ingredients in the food
supplement industry—require continuous efforts in awareness and prevention among primary producers. In
this context, Europam maintains an active dialogue with European institutions to ensure that limits for certain
contaminants are defined in a way that is both realistic and practically applicable by primary operators in the
supply chain. To achieve these goals, data collection and analysis are essential tools. As illustrative case
studies, we will present the issues related to pyrrolizidine alkaloids and mineral oil residues.

Director Scientific and Regulatory Affairs at Food Supplements Europe, Belgium
National regulatory developments are continuous and activity at EU level is expected. The presentation will explore what possibilities, but also what pitfalls exist for further European harmonisation on botanicals and how companies should be prepared.

Member of the Management Board Quality & Development at Finzelberg, Germany
Herbal medicines (phytopharmaceuticals) are an important component of our healthcare system and have become particularly established in self-medication. They are readily available and are particularly suitable for the treatment of minor ailments and illnesses. They are most commonly used as remedies for colds, stomach and digestive problems, and as sedatives. At the same time Botanicals are also used in Food Supplement with the purpose to supplement the daily diet.
The current regulatory frameworks for both categories allow a coexistence of sometimes the same herbal ingredient in herbal medicinal products and food supplements at the same time.
While the market for phytopharmaceuticals is neither characterized by a significant grows nor a high dynamic, many new products are launched as food supplements.
This is somehow incomprehensive as health claims can be made for herbal medicinal products, higher prices are usually achieved, and long-life cycles are characteristic for herbal medicinal products.
Why do companies do not invest in the development of “new” herbal medicinal products but prefer to develop new food supplements?
The presentation will provide answers and give reasons why botanicals will continue to play an important role in food supplements.

General Manager at Kaneka Nutrients Europe, Belgium

Professor em. for Healthy Ageing, University Medical Center Groningen, Netherlands

Professor em. for Healthy Ageing, University Medical Center Groningen, Netherlands
Micronutrients are essential for life and optimal health. The link between a sufficient intake and long-term health is well supported by science as well as health organizations. There is evidence from food and intake surveys in many countries that a sufficient intake of micronutrients often is not reached according to recommendations using RDAs as reference. A significant scientific and medical consensus exists as to the importance of an optimal level of micronutrient intake and status throughout the life course to foster a healthy life.
The presentation will provide an overview on nutritional needs, an approach on the analysis of optimal intake and status of micronutrients and the benefit for long term health.

Professor, Guelph University, Canada

Omega-3 fatty acids remain one of the most scientifically validated and commercially significant categories in the global supplement industry. Recent advances in clinical research continue to expand the understanding of their role in cardiovascular health, central nervous system function, and inflammatory conditions. At the same time, new areas of investigation—such as skin health, sports recovery, and the gut-brain axis—are opening fresh opportunities for innovation.
Consumer trends are also reshaping the omega-3 market. While fish oil softgels remain dominant, growth in gummies and plant-based alternatives reflects changing preferences for convenience, taste, and sustainability. Emerging demographic segments—such as children, active lifestyle consumers, and healthy aging populations—are driving demand for personalized and condition-specific formulations. Additionally, transparency, traceability, and environmental stewardship are becoming key purchase drivers, with sustainably sourced fish oils and algae-based omega-3s gaining momentum.
This presentation will explore the intersection of science and market dynamics, highlighting breakthrough research, evolving regulatory landscapes, and consumer behavior shifts. By combining clinical evidence with real-world insights, we will identify how the omega-3 category can continue to grow through innovation, education, and strategic alignment with the needs of modern consumers.

Business Development Manager, SGS Institut Fresenius, Germany
Ensuring the safety and quality of food supplements is a growing challenge due to increasing product diversity, globalized supply chains, and evolving regulatory requirements. This presentation outlines the essential analytical test scope required to meet both regulatory standards and consumer expectations. Key topics include identity verification of active ingredients, contaminant screening (e.g., heavy metals, pesticides, and microbiological hazards), and stability testing. By applying targeted and risk-based analytical strategies, manufacturers can ensure product integrity, safety, and compliance.

Global Segment Development Manager Dairy, Petfood, Confectionary & Healthfood, SGS Health & Nutrition, Germany

Business Development Director, Rubicon Bridge, UK

Vice President APAC at Phynova Group, Belgium
Balancing healthy blood glucose and insulin responses to meals, is foundational to Metabolic Health. The presentation will highlight key studies demonstrating this and will zoom in on a natural, safe, and clinically validated alpha-glucosidase inhibitor that is water extracted from white mulberry leaves (Morus alba). Branded as Reducose®, its elegant mode-of-action has a significant and immediate effect on lowering post-prandial blood glucose and insulin excursions. This helps consumers to cope with the metabolic challenges of modern diets often overloaded with sugar and starches.

Nutrition Science Manager, Balchem Corporation, Norway
Plant-rich diets are associated with numerous health and environmental benefits, but may present challenges for individuals to achieve essential mineral requirements. The exclusion of animal-derived foods from the diet and the increased presence of anti-nutritional factors from plant-based foods such as phytates can significantly impair the bioavailability of key minerals, including iron, calcium, magnesium, and zinc.
This presentation explores the role of chelated minerals—particularly mineral bisglycinates—as a to help overcome these nutritional challenges. Chelated minerals demonstrate enhanced bioavailability and reduced interaction with dietary inhibitors, offering a more efficient pathway for mineral absorption. Their unique molecular structure also contributes to improved gastrointestinal tolerability and greater formulation stability compared with other mineral formulations.
Supported by both preclinical and clinical evidence, chelated minerals are shown to be effective in improving mineral status in populations adhering to vegetarian and vegan dietary patterns. Their superior solubility and stability further support their use in advanced nutritional formulations, making them a valuable tool for clinicians and product developers aiming to optimize micronutrient delivery in plant-based nutrition.

Global Head of Innovation & Application Development Pharma & Nutrition, Budenheim, Germany
The talk explores the critical role of minerals and their functionality in the production of food supplements. Various case studies illustrate how functionality is essential for ensuring product quality and efficacy. The presentation will highlight the challenges and potential issues that can arise when functionality is not properly established, including compromised product performance and safety concerns. Additionally, it will emphasize the importance of verifying functionality, which is often overlooked in certificates of analysis. By addressing these aspects, the talk aims to provide a comprehensive understanding of the synergistic relationship between functionality and essential minerals, and its impact on product development and consumer health.

Professor em. for Healthy Ageing, University Medical Center Groningen, Netherlands
Opportunities for enhancing healthy longevity and rejuvenation are rapidly expanding, driven by breakthroughs in science, technology, and lifestyle interventions. First studies demonstrated that human biology can be optimized for greater longevity. The objective is to add life to the years rather than just years to life. Examples of interventions show promise in slowing down or even reversing age-related decline. The translation allows for more personalized care, combined with wearable devices and health apps monitoring biomarkers to optimize wellness.

Director R&D, DFS and Product Development at Lonza, France
As consumer demand for plant-based and clean-label supplements accelerates, innovation in capsule technology plays a pivotal role in shaping the future of supplement delivery.
This session will explore how Lonza’s advanced plant-based polymers are addressing key market trends, overcoming formulation challenges, and driving sustainability initiatives.
It will also provide supplement brands and formulators with key insights on implementing cutting-edge capsule solutions to meet evolving consumer expectations and enhance product performance.

Project nature4HEALTH, Institute of Nutritional Sciences, Friedrich Schiller University Jena, Germany
The concurrent use of medications and dietary supplements is widespread in clinical practice but entails significant risks of pharmacokinetic and pharmacodynamic interactions. This presentation is dedicated to the systematic analysis of interactions between micronutrients—particularly fat-soluble vitamins—and pharmaceuticals commonly used in cardiometabolic therapy. The focus is on drug interactions at the levels of absorption, metabolism, distribution, and elimination, mediated by key enzymatic systems such as cytochrome P450, transport proteins, and nuclear receptors. Well-known interactions are discussed as examples, demonstrating that supplements can either enhance (synergistically) or diminish (antagonistically) the effects of medications. These effects are of direct relevance for therapeutic safety and efficacy, especially in older, polymedicated, or predisposed patient populations. The contribution highlights the need for a nuanced assessment of such interactions, as well as adjustments to clinical guidelines and intake recommendations. The aim is to raise awareness of nutrient-drug interactions in everyday clinical practice and to promote evidence-based use of supplements.

Vice President Human Nutrition, Alzchem Trostberg, Germany

Professor, Guelph University, Canada